Tissue switching could lead to new diabetes treatment. You have full access to this article via your institution. A study using frogs hints that one day portions of diabetics' livers might be ...
A UCLA-developed nanoparticle is aiming to reprogram the liver in humans to attack pancreatic cancer with an mRNA vaccine (curved, hatched red lines) and an immune-activating fragment of genetic ...
Microscopic changes in the liver can be used to predict if, and where, pancreatic cancer may spread in the body. The discovery has the potential to provide new ways of predicting the course of the ...
A drug candidate discovered and developed decades ago in the laboratory of UC Davis distinguished professor Bruce Hammock may help control the body's raging and often deadly inflammatory response to ...
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address ...
Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “Doctors often use ‘normal’ ranges to say whether a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback